SOND — Hipgnosis Songs Fund Income Statement
0.000.00%
- $1.58bn
- $2.15bn
- $177.55m
- 14
- 27
- 94
- 39
Annual income statement for Hipgnosis Songs Fund, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2019 March 31st | R2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 10 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | fx Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 10.4 | 83.5 | 161 | 200 | 178 |
Cost of Revenue | |||||
Gross Profit | — | 83.3 | 138 | 168 | 147 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 6.52 | 42 | 116 | 217 | 264 |
Operating Profit | 3.89 | 41.5 | 44.5 | -16.7 | -86.6 |
Net Income Before Taxes | 3.89 | 41.5 | 44.5 | -16.7 | -86.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | 3.07 | 32 | 38.9 | -19.4 | -89.6 |
Net Income Before Extraordinary Items | |||||
Net Income | 3.07 | 32 | 38.9 | -19.4 | -89.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 3.07 | 32 | 38.9 | -19.4 | -89.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.015 | 0.082 | 0.048 | -0.014 | -0.068 |
Dividends per Share |